• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter Telegram
Iranian Journal of Basic Medical Sciences
Articles in Press
Current Issue
Journal Archive
Volume Volume 22 (2019)
Volume Volume 21 (2018)
Volume Volume 20 (2017)
Volume Volume 19 (2016)
Issue Issue 12
Issue Issue 11
Issue Issue 10
Issue Issue 9
Issue Issue 8
Issue Issue 7
Issue Issue 6
Issue Issue 5
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 18 (2015)
Volume Volume 17 (2014)
Volume Volume 16 (2013)
Volume Volume 15 (2012)
Volume Volume 14 (2011)
Volume Volume 13 (2010)
Volume Volume 12 (2009)
Volume Volume 11 (2008)
Volume Volume 10 (2007)
Iranian Journal of
Basic Medical Sciences
Rejection Rate 78.33%
Average time to first decision (days) 19.31

SCImago Journal & Country Rank

Ma, J., Feng, Y., Li, Z., Tang, C. (2016). The effect of adrenomedullin and proadrenomedullin N- terminal 20 peptide on angiotensin II induced vascular smooth muscle cell proliferation. Iranian Journal of Basic Medical Sciences, 19(1), 49-54. doi: 10.22038/ijbms.2016.6414
Jian Ma; Yinglu Feng; Zaiquan Li; Chaoshu Tang. "The effect of adrenomedullin and proadrenomedullin N- terminal 20 peptide on angiotensin II induced vascular smooth muscle cell proliferation". Iranian Journal of Basic Medical Sciences, 19, 1, 2016, 49-54. doi: 10.22038/ijbms.2016.6414
Ma, J., Feng, Y., Li, Z., Tang, C. (2016). 'The effect of adrenomedullin and proadrenomedullin N- terminal 20 peptide on angiotensin II induced vascular smooth muscle cell proliferation', Iranian Journal of Basic Medical Sciences, 19(1), pp. 49-54. doi: 10.22038/ijbms.2016.6414
Ma, J., Feng, Y., Li, Z., Tang, C. The effect of adrenomedullin and proadrenomedullin N- terminal 20 peptide on angiotensin II induced vascular smooth muscle cell proliferation. Iranian Journal of Basic Medical Sciences, 2016; 19(1): 49-54. doi: 10.22038/ijbms.2016.6414

The effect of adrenomedullin and proadrenomedullin N- terminal 20 peptide on angiotensin II induced vascular smooth muscle cell proliferation

Article 8, Volume 19, Issue 1, January 2016, Page 49-54  XML PDF (477 K)
Document Type: Original Article
DOI: 10.22038/ijbms.2016.6414
Authors
Jian Ma 1; Yinglu Feng1; Zaiquan Li2; Chaoshu Tang2
1Cadres Division One, The 401st Hospital of PLA, Qingdao 266071, China
2Institute of Cardiovascular Research, Peking Medical University, First Hospital, Beijing 100083, China
Abstract
Objective(s): The study aimed to investigate the effects of adrenomedullin (ADM) and proadrenomedullin N- terminal 20 peptide (PAMP) on angiotensin II (AngII)-stimulated proliferation in vascular smooth muscle cells (VSMCs).
Materials and Methods: Thoracic aorta was obtained from Wistar rats and VSMCs were isolated from aorta tissues and then cultured. In vitro cultured VSMCs were stimulated with Ang II (10-8 mol/l) followed by various doses of PAMP or ADM (10-9, 10-8, or 10-7 mol/l). Cell proliferation as assessed by 3H-TdR incorporation. Protein kinase C (PKC) activity was measured by counting γ-32P radioactivity with liquid scintillation. In a separate cohort, in vitro cultured rat aortic vessels were treated with different doses of Ang II or PAMP (10-9, 10-8, or 10-7 mol/l). Cellular and secreted levels of PAMP, ADM and Ang II were measured using radioimmunoassay in the tissues and intubation mediums, respectively.
Results: Ang II (10-8 mol/l) treatment significantly increased both 3H-TdR incorporation and PKC activity in VSMCs (by 2.68 and 1.02-fold, respectively; both P<0.01 vs. the control). However, Ang II-induced elevation of 3H-TdR incorporation, and PKC activity was significantly inhibited by various doses of ADM and PAMP (all P<0.01 vs. the Ang II group). In rat aortic vascular tissues or intubation media, Ang II treatments stimulated the expression and secretion of PAMP and ADM in a dose-dependent manner, while PAMP treatments had no significant effects on Ang II levels.
Conclusion: ADM and PAMP inhibit Ang II-induced VSMCs proliferation. The interaction of Ang II, ADM and PAMP may regulate VSMCs and cardiovascular function.
Keywords
Adrenomedulin; Angiotension II; Proadrenomedullin N-terminal 20 peptide; Proliferation; Vascular smooth muscle- cell
References

 

1. Nishikimi T, Kuwahara K, Nakagawa Y, Kangawa K, Nakao K. Adrenomedullin in cardiovascular diseases: a useful biomarker, its pathological roles and therapeutic application. Curr Protein Pept Sci 2013; 14:256-67.

2. Hirata Y, Takagi Y, Takata S, Fukuda Y, Yoshimi H, Fujita T. Calcitonin gene-related peptide receptor in cultured vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun 1988; 151:1113-1121.

3. Haller H, Baur E, Quass P, Behrend M, Lindschau C, Distler A, et al. High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 1995; 47:1057-1067.

4. Shimosawa T, Fujita T. Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide. Hypertension 1996; 28:325-329.

5. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201:1160-1166.

6. Eto T. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 2001; 22:1693-711.

7. Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, Kitamura K, et al. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 1995; 270:4412-4417.

8. Takano K, Yamashita N, Fujita T. Proadrenomedu-llin NH2-terminal 20 peptide inhibits the voltage-gated Ca2+ channel current through a pertussis toxin-sensitive G protein in rat pheochromocytoma-derived PC 12 cells. J Clin Invest 1996; 98:14-17.

9. Inatsu H, Sakata J, Shimokubo T, Kitani M, Nishizono M, Washimine H, et al. Distribution and characterization of rat immunoreactive proadreno-medullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat. Biochem Mol Biol Int 1996; 38:365-372.

10. Sims C, Ashby K, Douglas JG. Angiotensin II-induced changes in guanine nucleotide binding and regulatory proteins. Hypertension 1992; 19:146-152.

11. Andreis PG, Markowska A, Champion HC, Mazzocchi G, Malendowicz LK, Nussdorfer GG. Adrenomedullin enhances cell proliferation and deoxyribonucleic acid synthesis in rat adrenal zona glomerulosa: receptor subtype involved and signaling mechanism. Endocrinology 2000; 141:2098-2104.

12. Goichberg P, Kalinkovich A, Borodovsky N, Tesio M, Petit I, Nagler A, et al. cAMP-induced PKCzeta activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors. Blood 2006; 107:870-879.

13. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000; 21:138-167.

14.  Rossi F, Bertone C, Petricca S, Santiemma V. Adrenomedullin antagonizes angiotensin II-stimulated proliferation of human aortic smooth muscle cells. Peptides 2006; 27:2935-41.

15. Hamid SA, Baxter GF. Adrenomedullin: regulator of systemic and cardiac homeostasis in acute myocardial infarction. Pharmacol Ther 2005; 105:95-112.

Statistics
Article View: 1,130
PDF Download: 794
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by sinaweb.